Health Care: Drugs

Apricus Biosciences Inc (APRI: NASDAQ)

$1.91 -0.015 | -0.78%
03/27/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 9.26M 2.51M 8.42M 4.10M
Cost of Sales 748.00K 2.30M 12.57M 1.60M
Gross Operating Profit 8.51M 207.00K -4.15M 2.50M
Selling, General, and Administrative Expenses 11.42M 13.55M 15.38M 11.46M
Research & Development 21.29M 5.12M 5.38M 5.82M
Operating Income before D & A (EBITDA) -24.20M -18.47M -24.90M -14.78M
Depreciation & Amortization 170.00K 327.00K 240.00K 639.47K
Interest Income 0.00 0.00 0.00 13.73K
Other Income - Net 2.23M 3.65M 425.00K -2.33M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -22.14M -15.14M -24.72M -17.74M
Interest Expense 339.00K 727.00K 325.00K 376.92K
Pre-Tax Income -22.48M -15.87M -25.04M -18.12M
Income Taxes 0.00 0.00 516.00K 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -22.48M -15.87M -25.56M -18.12M
Net Income From Discontinued Operations 691.00K -1.07M -6.21M 0.00
Net Income From Total Operations -21.79M -16.94M -31.77M -18.12M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -21.79M -16.94M -31.77M -18.12M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-22.48M -15.87M -25.56M -18.12M
Preferred Dividends
Net Income Available To Common -22.48M -15.87M -25.56M -18.12M
Basic EPS from Continuing Ops. -0.57 -0.46 -0.93 -0.90
Basic EPS from Discontinued Ops. 0.02 -0.03 -0.23 0.00
Basic EPS from Total Operations -0.55 -0.49 -1.16 -0.90
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.55 -0.49 -1.16 -0.90
Basic Normalized Net Income/Share -0.57 -0.46 -0.93 -0.90
EPS fr Continuing Ops. -0.57 -0.46 -0.93 -0.90
EPS fr Discontinued Ops 0.02 -0.03 -0.23 0.00
EPS fr Total Ops. -0.55 -0.49 -1.16 -0.90
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.55 -0.49 -1.16 -0.90
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.57 -0.46 -0.93 -0.90
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with APRI

Latest APRI Headlines from TheStreet

More Financial News for APRI

Press Releases for APRI

See All Press Releases

Partner Headlines for APRI

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter